August 2014
www.nzmanufacturer.co.nz
COMPANY PROFILE
8
Bellamy & East.
PREVENTATIVE MAINTENANCE New inspection regime passes the test.
20
New opportunity for manufacturers Two Christchurch biotechnology companies, Olympic Biotec Ltd and Waitaki Biosciences, the trading division of PharmaZen Ltd, have pooled their expertise to produce the world’s first 100% krill powder. The Rimfrost Pristine Krill Powder was recently in the spotlight at Vitafoods Europe, Europe’s largest nutraceutical show, held in Geneva. Rimfrost Pristine is the first 100% krill powder to be developed internationally, offering a new opportunity for international manufacturers of nutraceuticals and health supplements to extend their range of health promoting omega-3
products – with potential benefits to cardiovascular and joint health among other uses. The two local companies worked jointly on this project over the past 12-18 months, leveraging off their respective strengths – the high-quality krill raw material of Olympic Biotec, coupled with the acknowledged manufacturing and processing capabilites of PharmaZen.
market opportunity that was a bit of a reach technically. We had a very open dialogue, bouncing concepts back and forward between the companies until we had the product finalised.” Early feedback from the market has been extremely positive and Olympic is now developing its global strategy to
Written in collaboration with Deloitte Touche Tohmatsu Limited, the study finds that the global manufacturing ecosystem is undergoing a dramatic transformation, with many emerging economies developing significant manufacturing and innovation
Olympic Biotec is one of the fastest growing companies in New Zealand’s biotechnology sector. It achieved sales of close to $10 million in 2012, its first year of operation and more than doubled that to well over $20 million by year end 2013.
John Cameron, managing director of Olympic Biotec Ltd, said it was extremely pleasing to reach this milestone after many months of research, development and refining the manufacturing process. PharmaZen CEO Craig McIntosh was delighted with his company’s involvement. ”Olympic Biotec identified a significant
Skill shortages a major concern Talent, the ability to innovate and the strategic use of public policy will play a significant role in defining manufacturing sector competitiveness in developed and emerging economies going forward, finds The Future of Manufacturing, a report by the World Economic Forum.
meet this demand, Mr Cameron said.
capabilities, enabling them to produce increasingly complex products, leading to the globalisation of manufacturing supply chains. Fading labour rate arbitrage, exposure to currency volatility, sovereign debt pressures and emerging protectionist policies will be countervailing forces to further globalisation of manufacturing value chains. The report highlights the key trends that will define manufacturing competition over the next 20 years and which will require the attention and collaboration of policy-makers, civil society and business leaders. With an estimated 10 million jobs with manufacturing organisations worldwide that cannot be filled today due to a growing skills gap, the report
identifies talent as one of the key differentiators that will define the future of the sector. The other top differentiators identified in the report include the strategic use of public policy and the ability to innovate. The infrastructure necessary to enable manufacturing to flourish and contribute to job growth will grow in importance and sophistication and be challenging for countries to develop and maintain. Growing materials resources competition and scarcity will fundamentally alter country and company resources strategies and competition, and serve as a catalyst to significant materials sciences breakthroughs.
10 million jobs with manufacturing organisations worldwide cannot be filled today due to a growing skills gap